Discover other Lawyers ranked in this practice area

2
Band 2
Cécile Théard-Jallu
2
Cécile Théard-Jallu
6 Years Ranked

De Gaulle Fleurance

View profile
Eveline Van Keymeulen
2
Eveline Van Keymeulen
6 Years Ranked

Latham & Watkins LLP

View profile
Sophie Pelé
2
Sophie Pelé
4 Years Ranked

Dechert LLP

View profile
3
Band 3
Charlotte Damiano
3
Charlotte Damiano
3 Years Ranked

Hogan Lovells

View profile
3
Julie Yeni
5 Years Ranked

Baker McKenzie

View profile
Mikael Salmela
3
Mikael Salmela
2 Years Ranked

Hogan Lovells

View profile
U
Up and Coming
Diane Bandon-Tourret
U
Diane Bandon-Tourret
2 Years Ranked

LexCase

View profile
Gaëlle Merlier
U
Gaëlle Merlier
3 Years Ranked

Delsol Avocats

View profile

Chambers Review

Provided by Chambers

Chambers France

Pharma/Life Sciences: Regulatory - France

3
Band 3
Individual Editorial

Thomas Devred of Osborne Clarke enters the rankings this year. He assists healthcare and pharmaceutical clients with a range of cases, including health data questions, environmental regulations and contractual disputes.

Strengths

I really like his availability and his willingness to help and to understand us as client.

Thomas is very involved and an asset thanks to his experience and knowledge of the needs of a pharmaceutical client.

Editorial individuel

Thomas Devred d’Osborne Clarke entre dans le classement cette année. Il assiste des clients du secteur de la santé et de l’industrie pharmaceutique dans un large éventail de dossiers, notamment des questions relatives aux données de santé, des réglementations environnementales et des litiges contractuels.

Points forts

J’aime beaucoup sa disponibilité et sa volonté de nous aider et de nous comprendre en tant que client.

Thomas est très impliqué et un atout grâce à son expérience et sa connaissance des besoins d’un client pharmaceutique.

Discover other Lawyers at
Osborne Clarke France

Provided by Chambers
Filter by
Band

France

Corporate/M&A: Mid-Market

1
David Haccoun
1
Band 1
Employment

5
Maxime Pigeon
5
Band 5
Environment

4
Joanna Peltzman
4
Band 4
Pharma/Life Sciences: Regulatory

3
Thomas Devred
3
Band 3
Real Estate

4
François-Régis Fabre-Falret
4
Band 4
Restructuring/Insolvency

5
Nassim Ghalimi
5
Band 5